Question Everything. See who's reporting it.

CDSCO targets unapproved enclomiphene drugs, compliance ongoing

Source: Mint / LiveMint

The story in brief

CDSCO has ordered action against unapproved enclomiphene drugs, which are used to treat male infertility. The DCGI is enforcing compliance, impacting India’s pharmaceutical market. Manufacturers must submit action-taken reports, while unapproved formulations without central safety evaluations are being targeted. Public health experts warn that consuming unapproved drugs can lead to poor treatment outcomes.

NEWXFree on Android and iPhone. Open in NEWX